Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis : workshop summary

Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis workshop summary

To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed with multidrug-resist...

Descripción completa

Detalles Bibliográficos
Autor principal: Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB (corporate author, -)
Autores Corporativos: Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB Corporate Author (corporate author), Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, issuing body (issuing body), Institute of Medicine (U.S.). Board on Health Sciences Policy, issuing body
Otros Autores: Nicholson, Anna, contributor (contributor)
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, District of Columbia : National Academies Press [2013]
Edición:1st ed
Materias:
Multidrug-resistant tuberculosis > Prevention > Congresses.
Business logistics > Congresses.
International cooperation > Congresses.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009621947206719
Tabla de Contenidos:
  • Logistics, Supply, and Demand
  • Financing of MDR TB SLDs
  • Innovative Suggestions and Potential Solutions.

Ejemplares similares